Stock Analysis
Danaher Corporation (DHR) Stock Analysis
Danaher Corporation (DHR) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Danaher Corporation (DHR) currently has an AIQ Score of 56/100, indicating a neutral setup. Momentum is the strongest factor at 80/100. Value is the weakest current factor at 33/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
DHR at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $232.23 |
| AIQ Score | 56/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $162.04B |
| P/E Ratio (TTM) | 37.66 |
| Forward P/E | — |
| EPS (quarter ended 2026-09-25) | $1.75 |
| Revenue (quarter ended 2026-09-25) | $6.55B |
| Dividend Yield (TTM) | 0.66% |
| Beta | 0.8 |
| Volume | 3.76M |
| 52-week range | $160.93-$242.80 |
| RSI 14 | 70.51 |
| 50-Day SMA | $218.53 |
| 200-Day SMA | $201.14 |
| Analyst Price Target | $233.47 |
| Next Earnings | Jan 27, 2027 |
DHRDanaher Corporation
Healthcare / Medical - Diagnostics & Research
Low Priority
Above Peers
Latest quote
- Momentum80
- Value33
- Quality57
- Risk resilience61
- Sentiment—
DHR Stock Analysis Summary
Danaher Corporation (DHR) currently has an AIQ Score of 56/100, indicating a neutral setup. Momentum is the strongest factor at 80/100. Value is the weakest current factor at 33/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, DHR has AIQ Score of 56/100 with Momentum base of 80/100 and fading Value at 33/100. Wait for component alignment before adding exposure.
Momentum (80/100) leads while Value (33/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · -2.00% stock move · DHR classified in Medical - Diagnostics & Research.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is DHR Bullish or Bearish Right Now?
DHR currently has a neutral overall setup. Momentum is the strongest factor at 80/100, while Value is weakest at 33/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Momentum is constructive at 80/100.
- - Risk Resilience is supportive at 61/100.
- - Price is +6.27% above its 50-day SMA.
- - Analyst target implies +0.53% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (37 vs 7).
- - Value is the current constraint at 33/100.
Current Consensus
DHR's Technical Analysis Consensus is currently Strong Buy, with 37 buy, 1 neutral, and 7 sell votes. DHR's 14-day RSI is 70.51, which places the stock in an overbought momentum range. DHR's beta is 0.8, indicating lower market sensitivity than the broad market.
What Changed in DHR?
The largest recent change in DHR is Momentum moving up by 4.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.
What Would Change the DHR Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
DHR Decision Framework
Public evidence layers, setup checks, and risk context for Danaher Corporation.
Danaher Corporation (DHR) Stock Analysis
Danaher Corporation has an AIQ Score of 56/100 in a Neutral regime. Momentum is strongest at 80/100. Beta is 0.8, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | DHR is in a Neutral AIQ regime with score 56/100. |
| Signal Conflict | The primary conflict is that momentum leads at 80/100 while value lags at 33/100. |
| Factor Evidence | Momentum 80/100 · Value 33/100 · Quality 57/100 · Risk 61/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 80/100.
Momentum is 80/100 and RSI (14) is 70.5.
DHR is in a Neutral regime at 56/100.
Risk factor is 61/100 with beta 0.8 and annual volatility 30.1%.
Current conflict: momentum leads at 80/100 while value lags at 33/100.
DHR Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
DHR Fundamentals
DHR valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
DHR Technical Analysis
DHR technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
DHR Stock Catalysts
Track DHR earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
DHR Dividend Analysis
DHR dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
DHR Financial Data
DHR revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
DHR Risk Analysis
DHR volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
DHR Stock News
DHR stock news, market tone, recent headlines, and catalyst context.
DHR vs Life Sciences / Tools / CRO Peers
Current peer cohort: DHR · EFX · EXAS · ILMN · LNTH. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| DHR Current stock | 56/100 | 33/100 | 80/100 | 61/100 | 0.36 | 30.10% | Current |
| EFX Equifax | 60/100 | 54/100 | 86/100 | 39/100 | -0.33 | 40.98% | DHR vs EFX |
| EXAS Exact Sciences | 46/100 | 37/100 | — | 67/100 | 3.02 | 44.36% | DHR vs EXAS |
| ILMN Illumina | 54/100 | 26/100 | 69/100 | 38/100 | 2.42 | 49.76% | DHR vs ILMN |
| LNTH Lantheus Holdings | 65/100 | 52/100 | 65/100 | 72/100 | 1.86 | 32.28% | DHR vs LNTH |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 30, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts4 recent quarterly periods are available for review.
Checked Oct 31, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Sep 25, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching DHR
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for DHR
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
DHR Stock FAQ
What is DHR stock price today?
Danaher Corporation's current stock price is $232.23. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is DHR bullish or bearish right now?
DHR's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is DHR's market cap?
DHR's market cap is $162.04B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is DHR's current P/E ratio?
DHR's current P/E ratio is 37.66 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is DHR's RSI?
DHR's 14-day RSI is 70.51 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is DHR above its 50-day and 200-day moving averages?
DHR is 6.27% from its 50-day SMA and 15.46% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is DHR's next earnings date?
DHR's next earnings date is currently listed as Jan 27, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does DHR pay a dividend?
DHR's dividend yield is 0.66% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.